Literature DB >> 26181139

Neoadjuvant Therapy in Breast Cancer as a Basis for Drug Approval.

Donald A Berry1, Clifford A Hudis2.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2015        PMID： 26181139     DOI： 10.1001/jamaoncol.2015.1293

Source DB:  PubMed          Journal:  JAMA Oncol        ISSN： 2374-2437            Impact factor:   31.777


× No keyword cloud information.
  17 in total

Review 1.  Neoadjuvant Therapy for Breast Cancer: Established Concepts and Emerging Strategies.

Authors:  Tessa G Steenbruggen; Mette S van Ramshorst; Marleen Kok; Sabine C Linn; Carolien H Smorenburg; Gabe S Sonke
Journal:  Drugs       Date:  2017-08       Impact factor: 9.546

2.  Breast-Conserving Therapy in Patients with cT3 Breast Cancer with Good Response to Neoadjuvant Systemic Therapy Results in Excellent Local Control: A Comprehensive Cancer Center Experience.

Authors:  Marieke E M van der Noordaa; Ileana Ioan; Emiel J Rutgers; Erik van Werkhoven; Claudette E Loo; Rosie Voorthuis; Jelle Wesseling; Japke van Urk; Terry Wiersma; Vincent Dezentje; Marie-Jeanne T F D Vrancken Peeters; Frederieke H van Duijnhoven
Journal:  Ann Surg Oncol       Date:  2021-05-12       Impact factor: 5.344

3.  Right-Sizing Adjuvant and Neoadjuvant Clinical Trials in Breast Cancer.

Authors:  Donald A Berry
Journal:  Clin Cancer Res       Date:  2015-10-28       Impact factor: 12.531

4.  Statistical controversies in clinical research: assessing pathologic complete response as a trial-level surrogate end point for early-stage breast cancer.

Authors:  E L Korn; M C Sachs; L M McShane
Journal:  Ann Oncol       Date:  2015-10-21       Impact factor: 32.976

5.  Long-Term Prognostic Risk After Neoadjuvant Chemotherapy Associated With Residual Cancer Burden and Breast Cancer Subtype.

Authors:  W Fraser Symmans; Caimiao Wei; Rebekah Gould; Xian Yu; Ya Zhang; Mei Liu; Andrew Walls; Alex Bousamra; Maheshwari Ramineni; Bruno Sinn; Kelly Hunt; Thomas A Buchholz; Vicente Valero; Aman U Buzdar; Wei Yang; Abenaa M Brewster; Stacy Moulder; Lajos Pusztai; Christos Hatzis; Gabriel N Hortobagyi
Journal:  J Clin Oncol       Date:  2017-01-30       Impact factor: 44.544

6.  Pathologic Complete Response after Neoadjuvant Chemotherapy and Impact on Breast Cancer Recurrence and Survival: A Comprehensive Meta-analysis.

Authors:  Laura M Spring; Geoffrey Fell; Andrea Arfe; Lorenzo Trippa; Aditya Bardia; Chandni Sharma; Rachel Greenup; Kerry L Reynolds; Barbara L Smith; Brian Alexander; Beverly Moy; Steven J Isakoff; Giovanni Parmigiani
Journal:  Clin Cancer Res       Date:  2020-02-11       Impact factor: 12.531

Review 7.  Translating neoadjuvant therapy into survival benefits: one size does not fit all.

Authors:  Leticia De Mattos-Arruda; Ronglai Shen; Jorge S Reis-Filho; Javier Cortés
Journal:  Nat Rev Clin Oncol       Date:  2016-03-22       Impact factor: 66.675

8.  Association of Minimal Residual Disease With Clinical Outcome in Pediatric and Adult Acute Lymphoblastic Leukemia: A Meta-analysis.

Authors:  Donald A Berry; Shouhao Zhou; Howard Higley; Lata Mukundan; Shuangshuang Fu; Gregory H Reaman; Brent L Wood; Gary J Kelloff; J Milburn Jessup; Jerald P Radich
Journal:  JAMA Oncol       Date:  2017-07-13       Impact factor: 31.777

9.  I-SPY 2: a Neoadjuvant Adaptive Clinical Trial Designed to Improve Outcomes in High-Risk Breast Cancer.

Authors:  Haiyun Wang; Douglas Yee
Journal:  Curr Breast Cancer Rep       Date:  2019-11-20

Review 10.  Refining neoadjuvant therapy clinical trial design for muscle-invasive bladder cancer before cystectomy: a joint US Food and Drug Administration and Bladder Cancer Advocacy Network workshop.

Authors:  Chana Weinstock; Matthew D Galsky; Elaine Chang; Andrea B Apolo; Rick Bangs; Stephanie Chisolm; Vinay Duddalwar; Jason A Efstathiou; Kirsten B Goldberg; Donna E Hansel; Ashish M Kamat; Paul G Kluetz; Seth P Lerner; Elizabeth Plimack; Tatiana Prowell; Harpreet Singh; Daniel Suzman; Evan Y Yu; Hui Zhang; Julia A Beaver; Richard Pazdur
Journal:  Nat Rev Urol       Date:  2021-09-10       Impact factor: 14.432
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.